Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.60 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.56 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.56 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.56 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.56 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.56 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.56 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | LAP3 | P28838 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | MTOR | P42345 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14534728 | 1.00 | OPRM1 (0.60) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL8980781 | 0.97 | PLA2G1B (0.60) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL237904 | 0.97 | PLA2G1B (0.60) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL5502787 | 0.97 | PLA2G1B (0.60) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL5500934 | 0.97 | PLA2G1B (0.60) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL2668921 | 0.97 | PLA2G1B (0.60) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL7610788 | 0.97 | PLA2G1B (0.60) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL12656375 | 0.97 | PLA2G1B (0.60) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| Hydrochloric Acid SCHEMBL21807740 | 0.97 | OPRM1 (0.57) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 | |
| SCHEMBL6644555 | 0.97 | PLA2G1B (0.60) | OPRM1PLA2G1BPLA2G2AS1PR2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117050256-A | Polymerizable composition | 华为技术有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-107245076-B | There are the one-dimensional organic semiconductor nanowires and its preparation method and application of fluorescence response to volatile organic compounds gas | 中国科学院化学研究所 | 2019-06-18 | — | — | CN | claimed |
| CN-107245076-A | There are one-dimensional organic semiconductor nanowires of fluorescence response and its preparation method and application to VOC gas | 中国科学院化学研究所 | 2017-10-13 | — | — | CN | claimed |
| CN-1747933-A | Novel monoacetyl o-phenylenediamine derivatives | HOFFMANN LA ROCHE (CH) | 2006-03-15 | — | — | CN | claimed |
| CN-1153562-C | Hair coloring compositions | �����غʱ�����˾ | 2004-06-16 | — | — | CN | claimed |
| US-20260108473-A1 | BISPECIFIC STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | GENERATION BIO CO (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260041643-A1 | STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | GENERATION BIO CO (US) | 2026-02-12 | — | — | US | disclosed |
| US-20250352666-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | GENERATION BIO CO (US) | 2025-11-20 | — | — | US | disclosed |
| US-12453706-B2 | Bispecific stealth lipid nanoparticle compositions for cell targeting | GENERATION BIO CO. (US) | 2025-10-28 | — | — | US | disclosed |
| US-20250186358-A1 | BISPECIFIC STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | GENERATION BIO CO. | 2025-06-12 | — | — | US | disclosed |
| US-12312312-B2 | Process for separating out an effluent obtained from an oligomerization step | IFP Energies Nouvelles (FR) | 2025-05-27 | — | — | US | disclosed |
| EP-3366669-B1 | MONOSUBSTITUTED OR POLYSUBSTITUTED AMPHIPHILIC HYPOCRELLIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND USES THEREOF | TECHNICAL INST OF PHYSICS AND CHEMISTRY OF THE CHINESE ACADEMY OF SCIENCES (CN) | 2025-05-21 | — | — | EP | disclosed |
| US-4458084-A | Cyclopentene derivatives | THE UPJOHN COMPANY (US) | 1984-07-03 | — | — | US | disclosed |
| US-4455430-A | ANTITUMOR AGENTS, MICROCIDES | THE UPJOHN COMPANY (US) | 1984-06-19 | — | — | US | disclosed |
| US-RE31578-E | ANTITUMOR AGENTS, BACTERICIDES | THE UPJOHN COMPANY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4298744-A | CHLORINATION OF ISOMERIC ANALOG | THE UPJOHN COMPANY (US) | 1981-11-03 | — | — | US | disclosed |
| US-4275214-A | ANALOGS OF TRICHOLOMIC ACID USEFUL AS INTERMEDIATES IN THE PREPARATION OF AT-125 | THE UPJOHN COMPANY (US) | 1981-06-23 | — | — | US | disclosed |
| US-4256898-A | INTERMEDIATES FOR MAKING (ALPHAS, 5S)-ALPHA-AMINO-3-CHLORO-2-ISOXAZOLINE-5-ACETIC ACID (AT-125) | THE UPJOHN COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
| US-4082792-A | SECONDARY ALKYL PRIMARY AMINE, ALKENOIC ACID, PRIMARY OR SECONDARY ALCOHOL | TEXACO INC. (US) | 1978-04-04 | — | — | US | disclosed |
| US-3976682-A | ALKYLAMMONIUM ALKYLAMINOALKANOATES, FREEZE-THAW ADDITIVE, CORROSION INHIBITOR, PIGMENT GRINDING | TEXACO INC. (US) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352666-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | LIPA, EYA3, EYA2 | OPRM1 4642/4885PLA2G1B 301/4885PLA2G2A 108/4885 |
| US-12453706-B2 | Bispecific stealth lipid nanoparticle compositions for cell targeting | CD47, MCL1, PLTP | OPRM1 4311/4885PLA2G1B 102/4885PLA2G2A 42/4885 |
| US-20260041643-A1 | STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | CD4, CD47, PBK | OPRM1 3827/4885PLA2G1B 1280/4885PLA2G2A 169/4885 |
| US-20260108473-A1 | BISPECIFIC STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | CD47, PLTP, CETP | OPRM1 3532/4885PLA2G1B 799/4885PLA2G2A 148/4885 |
| US-20250186358-A1 | BISPECIFIC STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | CD47, MCL1, PLTP | OPRM1 4311/4885PLA2G1B 102/4885PLA2G2A 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.